Professor Robert Perneczky

MD MBA

Department of Neuroscience

Chair in Translational Dementia Research

Professor Robert Perneczky
r.perneczky@sheffield.ac.uk
+44 114 222 2295

Full contact details

Professor Robert Perneczky
Department of Neuroscience
Sheffield Institute for Translational Neuroscience (SITraN)
385a Glossop Road
Sheffield
S10 2HQ
Profile
  • 2022-present: Professor of Translational Dementia Research, University of Sheffield, Sheffield, UK
  • 2016-present: Professor/Head of Division of Old Age Psychiatry, Ludwig-Maximilians-University Munich/University Hospital LMU Munich, Germany
  • 2016-present: PI/Research group leader, German Center for Neurodegenerative Diseases (DZNE) Munich, Germany
  • 2012-2018: Reader in Dementia Research/Co-Head of Department/Consultant Psychiatrist, Imperial College London, School of Public Health, London, UK
  • 2002-2013: Assistant doctor/consultant psychiatrist, Technical University Munich, Department of Psychiatry, Munich, Germany
  • 2001: Qualification at Technical University Munich, Germany
Research interests
  • Alzheimer’s disease fluid biomarkers (blood, CSF, RNA)
  • Neuroimaging (MRI, PET)
  • Neuroepidemiology
  • Pharmacological and non-pharmacological prevention/treatment of dementia
  • Frontotemporal dementia, atypical Parkinson’s disease
  • Healthcare preparedness in dementia
Teaching interests

Old age psychiatry

Professional activities
  • Member of the German memory clinics network executive board
  • Member of the University of Sheffield BRC executive board
  • Member of the University of Sheffield, Neuroscience Flagship Institute executive board (Translational Neuroscience theme co-lead)
Current Projects
  • Mechanisms of Amyloid Clearance in Alzheimer’s disease and other neurodegenerative diseases (AmyClear), funded by VERUM Foundation, Germany and University of Sheffield BRC
  • Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer’s disease (ActiGliA), funded by German Excellence Initiative and German Center for Neurodegenerative Disorders
  • Non-pharmacological treatment of challenging behaviour in dementia, funded by Robert-Vogel-Foundation, Germany